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Background/introduction
Temporal lobe epilepsy (TLE) is the most common
pharmacologically refractory form of epilepsy. While it
can often be effectively treated by temporal lobe surgery,
that does not always eliminate seizures, and many
patients are not suitable candidates for surgery. A non-
invasive method to augment surgical or medical treat-
ment of TLE would be highly useful. Low-intensity
focused ultrasound pulsation (LIFUP) offers the poten-
tial for non-invasive neuromodulation, and in animal
studies has not shown any evidence of tissue damage.
However, the technology has not yet been tested in
humans. We are currently testing the safety and feasibil-
ity of using a LIFUP device on humans to modulate
brain activity in the temporal lobe.
Methods
Participants will be recruited from patients with temporal
lobe epilepsy treated by the UCLA Seizure Disorder Cen-
ter’s who have elected to undergo temporal lobe surgery.
In the week prior to the scheduled surgery participants
will undergo simultaneous LIFUP and fMRI using various
LIFUP pulsing paradigms to excite or suppress neural tis-
sue. The BOLD signal will be analyzed to determine
whether LIFUP can activate or suppress region-specific
neural activity in the temporal lobe. LIFUP will be admi-
nistered at 3 different intensities.
To help determine safety of LIFUP participants will
also undergo pre- and post-EEG and neuropsychological
testing. To determine whether or not LIFUP causes tissue
damage, post- surgery samples of the resected temporal
lobe tissue in both sonicated and un-sonicated areas will
undergo histological analysis.
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